F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of established infection control guidelines, facility policy, and residents' clinical records, as
well as observations and staff interviews, it was determined that the facility failed to follow infection control
guidelines from the Centers for Medicare/Medicaid Services (CMS) and the Centers for Disease Control
(CDC) to reduce the spread of infections and prevent cross-contamination for one of five residents reviewed
(Resident 1).
Residents Affected - Few
Findings include:
CDC guidance on isolation precautions and Implementation of Personal Protective Equipment (PPE) use in
Nursing Homes to Prevent Spread of Multidrug-Resistant Organisms (MDRO's - bacteria that have become
resistant to certain antibiotics, and these antibiotics can no longer be used to control or kill the bacteria),
dated July 12, 2022, indicates that MDRO transmission is common in skilled nursing facilities, contributing
to substantial resident morbidity and mortality and increased healthcare costs. Enhanced Barrier
Precautions (EBP) are an infection control intervention designed to reduce transmission of resistant
organisms that employs targeted gown and glove use during high contact resident care activities. CMS
updated its infection prevention and control guidance effective April 1, 2024. The recommendations now
include the use of EBP during high-contact care activities for residents with chronic wounds or indwelling
medical devices, regardless of their MDRO status, in addition to residents who have an infection or
colonization with a CDC-targeted or other epidemiologically important MDRO when contact precautions do
not apply.
The facility's policy regarding EBP, dated May 8, 2024, indicated that EBP's would be indicated for residents
with wounds or indwelling medical devices, and infection or colonization with an MDRO. Healthcare
personnel were to wear appropriate PPE, including gloves and gowns, when providing care to residents
requiring EBP's.
The facility's pharmacy policy regarding medication administration, dated May 8, 2024, indicated that staff
were not to touch tablets or capsules with their fingers.
An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 2, dated February 26, 2025, indicated that the resident was cognitively impaired,
required assistance with care needs, had an indwelling catheter (a thin, flexible tube inserted into the
bladder to drain urine from the bladder), received insulin injections, and had diagnoses that included
diabetes and neurogenic bladder (bladder lacks control due to nerve or muscle problems).
A physician's order and care plan for Resident 1, dated February 19, 2025, included an order for the
resident to have a urinary (foley) catheter (an indwelling catheter) and EBP's for the use of the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395514
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395514
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Maybrook Hills Rehabilitation and Healthcare Cente
301 Valley View Boulevard
Altoona, PA 16602
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
indwelling catheter. The physician's orders also included orders for the resident to receive 27 units of Insulin
Glargine subcutaneously (beneath the skin) one time a day for diabetes, 4 percent Lidocaine External
Patch to be applied to the lower back topically one time a day for pain, and 0.4 milligrams/hour Nitroglycerin
Transdermal Patch to be applied one time a day for angina (chest pain).
Observations of medication pass on March 5, 2025, at 9:40 a.m. and 10:04 a.m. revealed that Licensed
Practical Nurse 1, while not wearing gloves, spilled a cup of prepared medications onto the top of the
medication cart, picked them up and put them back into the cup, and administered them to Resident 1. She
continued to feel Resident 1's lower back and applied the Lidocaine patch, cleaned the resident's abdomen
with alcohol and administered his Insulin Glargine, and removed the Nitroglycerin patch from his right upper
chest. During the medication pass Licensed Practical Nurse 1 dropped the Lisinopril pill onto the floor and
returned to the medication cart to prepare another dose. While preparing the dose of Lisinopril, without
gloves on, she spilled the pill onto the top of the medication cart and picked it up with her fingers, put it
back into the medication cup and administered it to the resident. She then applied the Nitroglycerin patch to
the resident's left upper chest. Licensed Practical Nurse 1 did not wear any PPE during the administration
of medications to Resident 1.
Interview with Licensed Practical Nurse 1 on March 5, 2025, at 10:12 a.m. revealed that she did not think
that Resident 1 was on EBP and that she never wears gloves when administering insulin pens or applying
medicated patches, and confirmed that she did not use gloves when touching the resident's spilled
medication, since her hands had been washed prior.
Interview with the Director of Nursing on March 5, 2025, at 1:55 p.m. confirmed that Resident 1 was on
EBP, and that Licensed Practical Nurse 1 should have been wearing a gown and gloves while providing
direct care to the resident.
28 Pa. Code 201.14(a) Responsibility of Licensee.
28 Pa. Code 201.18(e)(1) Management.
28 Pa. Code 211.12(d)(1)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395514
If continuation sheet
Page 2 of 2